Mayfair Pharmacare Limited - Accounts to registrar (filleted) - small 18.2
Mayfair Pharmacare Limited - Accounts to registrar (filleted) - small 18.2
| REGISTERED NUMBER: |
| Report of the Director and |
| Financial Statements for the Year Ended 30th April 2021 |
| for |
| MAYFAIR PHARMACARE LIMITED |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Contents of the Financial Statements |
| for the year ended 30th April 2021 |
| Page |
| Company Information | 1 |
| Report of the Director | 2 |
| Balance Sheet | 3 |
| Notes to the Financial Statements | 4 |
| MAYFAIR PHARMACARE LIMITED |
| Company Information |
| for the year ended 30th April 2021 |
| DIRECTOR: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| AUDITORS: |
| 2 Burton House |
| Repton Place |
| White Lion Road |
| Amersham |
| Buckinghamshire |
| HP7 9LP |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Report of the Director |
| for the year ended 30th April 2021 |
| The director presents his report with the financial statements of the company for the year ended 30th April 2021. |
| PRINCIPAL ACTIVITY |
| The principal activity of the company in the year under review was that of retail dispensing pharmacy and provision of ancillary treatment and services. |
| DIRECTOR |
| STATEMENT OF DIRECTOR'S RESPONSIBILITIES |
| The director is responsible for preparing the Report of the Director and the financial statements in accordance with applicable law and regulations. |
| Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the director is required to: |
| - | select suitable accounting policies and then apply them consistently; |
| - | make judgements and accounting estimates that are reasonable and prudent; |
| - | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. |
| The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. |
| STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS |
| So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information. |
| AUDITORS |
| The auditors, Jacquards Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting. |
| This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies. |
| ON BEHALF OF THE BOARD: |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Balance Sheet |
| 30th April 2021 |
| 2021 | 2020 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 4 |
| Tangible assets | 5 |
| Investment property | 6 |
| CURRENT ASSETS |
| Stocks |
| Debtors | 7 |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year | 8 |
| NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CREDITORS |
| Amounts falling due after more than one year |
9 |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital | 10 |
| Retained earnings |
| SHAREHOLDERS' FUNDS |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements were approved by the director and authorised for issue on |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Notes to the Financial Statements |
| for the year ended 30th April 2021 |
| 1. | STATUTORY INFORMATION |
| Mayfair Pharmacare Limited is a |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Turnover |
| Turnover represents sales of goods and services, excluding value added tax. |
| Goodwill |
| Goodwill, being the amount paid in connection with the acquisition of intangible assets is being amortised evenly over its estimated useful life of ten years. |
| Intangible assets |
| Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. |
| Tangible fixed assets |
| Leasehold property | - over lease term |
| PLant and machinery | - 25% straight line |
| Fixtures, fittings and equipment | - 20% straight line |
| Investment property |
| Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss. |
| Stocks |
| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Notes to the Financial Statements - continued |
| for the year ended 30th April 2021 |
| 2. | ACCOUNTING POLICIES - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Hire purchase and leasing commitments |
| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| 4. | INTANGIBLE FIXED ASSETS |
| Goodwill |
| £ |
| COST |
| Additions |
| At 30th April 2021 |
| AMORTISATION |
| Charge for year |
| At 30th April 2021 |
| NET BOOK VALUE |
| At 30th April 2021 |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Notes to the Financial Statements - continued |
| for the year ended 30th April 2021 |
| 5. | TANGIBLE FIXED ASSETS |
| Plant and |
| machinery |
| etc |
| £ |
| COST |
| Additions |
| At 30th April 2021 |
| DEPRECIATION |
| Charge for year |
| At 30th April 2021 |
| NET BOOK VALUE |
| At 30th April 2021 |
| 6. | INVESTMENT PROPERTY |
| Total |
| £ |
| FAIR VALUE |
| At 1st May 2020 |
| Disposals | ( |
) |
| At 30th April 2021 |
| NET BOOK VALUE |
| At 30th April 2021 |
| At 30th April 2020 |
| 7. | DEBTORS |
| 2021 | 2020 |
| £ | £ |
| Amounts falling due within one year: |
| Trade debtors |
| Amounts owed by group undertakings |
| Amounts owed by participating interests | - | 16,096 |
| Other debtors |
| Amounts falling due after more than one year: |
| Other debtors |
| Aggregate amounts |
| MAYFAIR PHARMACARE LIMITED (REGISTERED NUMBER: 07147533) |
| Notes to the Financial Statements - continued |
| for the year ended 30th April 2021 |
| 8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 2021 | 2020 |
| £ | £ |
| Trade creditors |
| Taxation and social security |
| Other creditors |
| 9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |
| 2021 | 2020 |
| £ | £ |
| Other creditors |
| Amounts falling due in more than five years: |
| Repayable otherwise than by instalments |
| Participators' loans | - | 189,565 |
| 10. | CALLED UP SHARE CAPITAL |
| Allotted, issued and fully paid: |
| Number: | Class: | Nominal | 2021 | 2020 |
| value: | £ | £ |
| Ordinary | £1 | 100 | 100 |
| Ordinary "A" | £1 | 75 | 75 |
| Ordinary "B" | £1 | 25 | 25 |
| 200 | 200 |
| 11. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |
| Jacquards Limited - Statutory Auditors |
| 12. | ULTIMATE CONTROLLING PARTY |
| The company is a wholly owned subsidiary of Radiant Medicare Limited, a company incorporated in England & Wales. The ultimate controlling party is the Radia family who own the entire issued share capital of Radiant Medicare Limited. |